← Evidence map

ArticleFrontiers in genetics2025

Recognition of HSPB8 as a potential therapeutic target for prostate cancer.

Xun Fu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41190325